Natco Pharma surges on launching Hepatitis C drug Velpanat in India

08 May 2017 Evaluate

Natco Pharma is currently trading at Rs. 916.80, up by 15.25 points or 1.69% from its previous closing of Rs. 901.55 on the BSE.

The scrip opened at Rs. 910.00 and has touched a high and low of Rs. 923.50 and Rs. 903.50 respectively. So far 10495 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1015.00 on 18-Apr-2017 and a 52 week low of Rs. 440.00 on 11-May-2016.

Last one week high and low of the scrip stood at Rs. 930.00 and Rs. 883.00 respectively. The current market cap of the company is Rs. 16014.53 crore.

The promoters holding in the company stood at 51.24%, while institutions and non-institutions held 26.70% and 22.05% respectively.

Natco Pharma has launched a generic version of sofosbuvir 400 mg / velpatasvir 100 mg fixed dose combination in India. Sofosbuvir 400 mg / velpatasvir 100 mg fixed dose combination is sold by Gilead Sciences, globally, under the brand name Epclusa.

Epclusa is the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection. Epclusa is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated).

Natco will market sofosbuvir 400 mg / velpatasvir 100 mg under the brand name Velpanat. Natco priced its generic medicine of VELPANAT at an MRP of Rs 18500 for a bottle of 28 tablets in India. Natco has signed a nonexclusive licensing agreement with Gilead Sciences, Inc., to manufacture and sell generic versions of its chronic hepatitis C medicines in 101 developing countries.

Natco Pharma Share Price

831.75 -2.10 (-0.25%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×